Impact and Therapeutic Potential of PPARs in Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|9|4|643-650

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.9, Iss.4, 2011-12, pp. : 643-650

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Potential in Alzheimer Disease

By  

Current Medicinal Chemistry, Vol. 9, Iss. 17, 2002-09 ,pp. : 1605-1610

Bentham Science Publishers

Access to resources Recommend Favorite

The therapeutic potential of the endocannabinoid system for Alzheimer's disease

By Karl Tim   Cheng David   Garner Brett   Arnold Jonathon C.  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 4, 2012-04 ,pp. : 407-420

Informa Healthcare

Access to resources Recommend Favorite

Potential therapeutic targets for Alzheimer’s disease

By McKeon-O’Malley C.   Saunders A.J.   Bush A.I.   Tanzi R.E.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 2, 1998-12 ,pp. : 157-179

Informa Healthcare

Access to resources Recommend Favorite

Potential Therapeutic Effects of Oleuropein Aglycone in Alzheimer's Disease

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 11, 2016-09 ,pp. : 994-1001

Bentham Science Publishers

Access to resources Recommend Favorite

PPARs: A Potential Target for a Disease-Modifying Strategy in Stroke

By  

Current Drug Targets, Vol. 14, Iss. 7, 2013-06 ,pp. : 752-767

Bentham Science Publishers

Access to resources Recommend Favorite